Multiphasic roles for matrix metalloproteinases after stroke.
about
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderBiphasic mechanisms of neurovascular unit injury and protection in CNS diseasesEnriched housing enhances recovery of limb placement ability and reduces aggrecan-containing perineuronal nets in the rat somatosensory cortex after experimental strokeAge and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic strokeMatrix metalloproteinase 10 gene polymorphism and atherothrombotic cerebral infarction risk in a Han Chinese populationα2-Antiplasmin: New Insights and Opportunities for Ischemic Stroke.The Concise Guide to PHARMACOLOGY 2013/14: enzymes.Magnetic resonance imaging of ischemia viability thresholds and the neurovascular unit.Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.Mmp-9, a potential target for cerebral ischemic treatment.MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.The proteome of human brain after ischemic stroke.Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activatorIncreased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke.Peroxynitrite decomposition catalyst prevents matrix metalloproteinase activation and neurovascular injury after prolonged cerebral ischemia in rats.Valproic acid attenuates blood-brain barrier disruption in a rat model of transient focal cerebral ischemia: the roles of HDAC and MMP-9 inhibition.Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentialsA dual role for microglia in promoting tissue inhibitor of metalloproteinase (TIMP) expression in glial cells in response to neuroinflammatory stimuliMMP-9 gene deletion mitigates microvascular loss in a model of ischemic acute kidney injury.Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor.MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis.Vascular Protection Following Cerebral Ischemia and Reperfusion.MiR-335 Regulates Hif-1α to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models.Human neural stem cells rapidly ameliorate symptomatic inflammation in early-stage ischemic-reperfusion cerebral injury.Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke.Endothelial cells and astrocytes: a concerto en duo in ischemic pathophysiology.Matrix Metalloproteinase Expression in Contusional Traumatic Brain Injury: A Paired Microdialysis Study.The neurovascular unit and combination treatment strategies for strokeChronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic strokeDietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins.Extracellular Matrix Modulation Is Driven by Experience-Dependent Plasticity During Stroke Recovery.Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.Unfractionated bone marrow cells attenuate paraquat-induced glomerular injury and acute renal failure by modulating the inflammatory response.Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.Fluorometric immunocapture assay for the specific measurement of matrix metalloproteinase-9 activity in biological samples: application to brain and plasma from rats with ischemic strokeExpression and Activity of Metalloproteinases in Depression.Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.
P2860
Q24626017-5F4CE38A-172D-46B5-8CDD-5FC92ACCA6E0Q26827146-9B7D4C4C-B4C5-4587-89A0-D6A5730E9106Q27312472-E8AC9AE3-8004-4B99-AD09-A5CAEE999FA9Q28391839-792BABCE-460F-46D5-8BA1-264F673170F2Q28689904-15974F1F-7DDA-423E-8859-FAB1B0CA1F49Q30248728-98CC14C2-0A6B-4F50-9187-89FBE70EF92CQ30486745-1F865DF4-5D7D-4AE8-9E43-511C93544D3DQ30634170-51606581-33B3-49CF-A0D7-2A515487B12DQ33539984-2FD9263A-EF31-4E98-928B-6A0B69B0E125Q33566724-B11A3376-9C1B-403E-80E7-9823B5ECC321Q33612510-DF2A3B4E-873D-459E-BF58-DA2FD777BC86Q33709032-DE5C89F1-7B5D-40A2-A682-58E8D383DBEAQ33715975-CEDE6177-6B9E-4AB9-A749-78A346F46661Q33823616-E73601FD-F1F4-46E3-89B6-ED9AC62E6997Q33889047-AE1810A9-B1B2-4C6F-88D2-CAAEDD9DB29DQ34281028-CB16B224-5587-4C44-B446-4D02B716EFBEQ34627485-949F8ACA-622B-4A5B-96DD-CAEA91E96B97Q34801330-1D011CF9-B95E-4C29-AB82-DFAC6AA0691DQ34972793-C699EC0C-4A89-4DE2-8E2D-94BB11C6668DQ35061225-EA5472A3-A5E1-4485-B95E-72A196A4EB7CQ35086941-8CB7FB3D-4F9A-435B-A8A7-E8E9130BFA18Q35148218-52152BAB-454D-4FAB-A1B4-A1472DC0B7B6Q35216111-52200BC2-7734-4169-9C2B-5D76FE7F27E9Q35551681-FCA2BAA0-91F8-4E68-8FA5-FE83D6AF49FEQ35648315-5B894717-FA41-42E4-81A0-FCA2BB45D26DQ35654807-D360F283-6A04-47AF-8654-61CF50231FE8Q35777502-97A03005-3F7B-4CA3-81D2-8886FE0F745AQ36072867-CD03D5E3-72AE-47D5-8FA2-7E62017D61F7Q36123018-33EB0769-D66C-450E-B4AF-5EB64D08FA98Q36124038-F78332AB-91A1-4FEE-8D17-0CC9B961D9D6Q36195297-0066A91F-CE12-4DC5-98A6-23A16624C92EQ36237752-22603738-F5C5-494E-81BA-0747F69DCC21Q36307057-1716AF73-4D82-4D4C-A98E-E399DBACBA3EQ36644315-17BF6887-9780-4FA2-B787-ABBE2C052ECEQ36700231-CB11ADD8-B2B7-4172-BC39-B5503662A0B4Q36736442-83DAE961-D745-4401-9E98-FDA16646B9AFQ36750801-729FB3A9-061A-418B-B3CA-8B65D73BC8CAQ36833684-3F94035B-5F57-4F8C-BFE3-593F533A8FE3Q37024770-7D051F56-673B-47F4-AEF9-C0B055153AB5Q37158226-1E61DC60-1DA8-497D-9CF2-903311034FDD
P2860
Multiphasic roles for matrix metalloproteinases after stroke.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiphasic roles for matrix metalloproteinases after stroke.
@en
Multiphasic roles for matrix metalloproteinases after stroke.
@nl
type
label
Multiphasic roles for matrix metalloproteinases after stroke.
@en
Multiphasic roles for matrix metalloproteinases after stroke.
@nl
prefLabel
Multiphasic roles for matrix metalloproteinases after stroke.
@en
Multiphasic roles for matrix metalloproteinases after stroke.
@nl
P1476
Multiphasic roles for matrix metalloproteinases after stroke.
@en
P2093
P356
10.1016/J.COPH.2007.12.001
P577
2008-01-15T00:00:00Z